Layn to showcase botanical extracts and host education session at SupplySide West 2024
Layn will showcase botanical extracts and polyphenols that support oxidative stress.
Photo © iStockphoto.com/Ulga
Layn Natural Ingredients (Irvine, CA) will be at SupplySide West 2024 in Las Vega, NV on October 30-31 to showcase a range of botanical ingredients. According to the company's press release, these ingredients include:
- SophorOx – An ingredient that is clinically demonstrated to reduce oxidative stress, support weight management, and support energy and stamina.
- Leafanine – A premium 98% L-theanine sourced entirely from Camellia sinensis (green tea)
- Bio+ Line – A range of trending ingredients known for their bioavailability and health benefits, including:
- Bio+Quercitrin
- Bio+Resveratrol
- Lipid-soluble tea polyphenols
- Tea and other key botanical ingredients, including:
- Tea extracts and instant tea powders – green, black, white, oolong and pu-erh
- Extracts of broccoli seed, gotu kola, pomegranate, rhodiola and more
The company’s chief science officer, James Roza, will also be leading an exclusive breakfast brief on Wednesday, October 30 from 9-10AM on the lower level of the South Pacific Ballroom B, where he will present a presentation called: “Oxidative Stress Reduction Using Novel Polyphenolic Compounds to Improve Health and Well-Being.” During this presentation, Roza will delve into the role of polyphenols for mitigating oxidative stress and promoting a healthier lifespan. Attendees can register for this session here.
Layn will be located at booth #4443.
Kratom sees impressive sales growth despite its regulatory status and stigma
March 12th 2025Despite its controversy, kratom is a top-selling ingredient that consumers see value in. That said, brands need to work hard to demonstrate safety and quality of kratom products in the absence of legal regulatory status. Will kratom be able to overcome its stigma for even more growth and consumer acceptance?
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
HHS announces efforts to eliminate independent conclusion of GRAS
Published: March 11th 2025 | Updated: March 11th 2025U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.
